In contrast to p53LKO mice, tumor formation was significantly delayed in p53/f control mice (Fig. 1j): up to the age of 90 weeks, the tumor incidence was 34.6% in males and 31.8% in female p53f/f mice. The gene discussed is TP53; the disease is neoplasm.